Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HYLASINE

K-Number: K993362 · 2000-03-13

Decision Date2000-03-13
Product CodeEMX
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

HYLASINE is the device name listed in this FDA 510(k) record. The listed applicant is Biomatrix, Inc.. It received FDA 510(k) clearance on 2000-03-13 under 510(k) number K993362. The device is classified under product code EMX. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HYLASINE?

HYLASINE is a medical device that received FDA 510(k) clearance on 2000-03-13. The listed applicant is Biomatrix, Inc.. The 510(k) number is K993362.

When did HYLASINE receive FDA 510(k) clearance?

HYLASINE received FDA 510(k) clearance on 2000-03-13, under 510(k) number K993362.

Who is the listed applicant for HYLASINE?

The FDA 510(k) record lists Biomatrix, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HYLASINE?

The FDA product code for HYLASINE is EMX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Biomatrix, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: EMX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑